Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Dynasore: Unlocking Endocytosis Pathways in Infectious Di...

    2025-12-29

    Dynasore: Unlocking Endocytosis Pathways in Infectious Disease Models

    Introduction

    Endocytosis is a fundamental cellular process central to signal transduction, protein biosynthesis, and membrane trafficking. Its dysregulation is implicated in cancer, neurodegeneration, and viral pathogenesis. Dynasore (SKU: A1605), a potent and reversible dynamin GTPase inhibitor, has emerged as a cornerstone tool for dissecting dynamin-dependent endocytosis and vesicle trafficking pathways.

    While existing literature has highlighted Dynasore’s roles in cancer biology, neurodegenerative disease models, and vesicle trafficking (see scenario-driven analysis; explore workflows in cancer and neurodegeneration), this article delves deeper into its mechanistic utility in infectious disease research. Specifically, we examine how Dynasore’s noncompetitive inhibition of dynamin GTPases enables precise elucidation of viral entry mechanisms, with a focus on pH- and clathrin-mediated endocytosis.

    Mechanism of Action of Dynasore: Molecular Insights

    Dynamin GTPase Function and Inhibition

    Dynamins are large GTPases integral to the fission of clathrin-coated vesicles from the plasma membrane during endocytosis. They hydrolyze GTP, driving conformational changes that sever budding vesicles, enabling the internalization of receptors, nutrients, and pathogens. The three primary isoforms—dynamin1, dynamin2, and Drp1—are pivotal for diverse cellular processes including signal transduction pathway study, protein biosynthesis, and synaptic vesicle endocytosis inhibition.

    Dynasore, as a small-molecule, cell-permeable, noncompetitive GTPase inhibitor, binds to dynamins at an allosteric site distinct from the GTP binding pocket. With an IC50 of 15 µM, it effectively blocks GTP hydrolysis, thereby arresting dynamin-dependent endocytosis. Unlike competitive inhibitors, Dynasore’s noncompetitive mechanism ensures robust inhibition across varying GTP concentrations, making it especially valuable for quantitative endocytosis research and reproducible experimental design.

    Reversibility and Cellular Compatibility

    One of Dynasore’s distinguishing features is its reversible inhibition. Upon removal, dynamin activity and endocytic flux rapidly resume, permitting dynamic studies of vesicle trafficking pathway modulation. This reversibility is essential for dissecting temporally regulated processes such as synaptic vesicle recycling and acute signal transduction events.

    In practice, Dynasore has demonstrated efficacy in diverse cell types, including HL-1 cardiomyocytes and neurons. Its ability to inhibit transferrin uptake and synaptic vesicle endocytosis with high specificity underpins its widespread adoption in biomedical research.

    Dynasore in Infectious Disease Models: A New Frontier

    Dissecting Viral Entry Pathways with Dynasore

    Infectious diseases, particularly those mediated by viruses exploiting host endocytic machinery for cell entry, present a formidable challenge for molecular dissection. Dynasore’s precision as a dynamin-dependent endocytosis inhibitor uniquely positions it for mechanistic studies of viral internalization. A seminal investigation (Wang et al., 2018) leveraged Dynasore to unravel the entry mechanism of genotype III grass carp reovirus (GCRV104) in fish kidney cells.

    Wang and colleagues demonstrated that prophylactic treatment with Dynasore significantly reduced GCRV104 infection, implicating dynamin-mediated, clathrin-dependent endocytosis as the critical route for viral entry. Notably, the study provided direct evidence that GCRV104 enters cells via a pH-dependent, dynamin-driven process—findings unattainable without the specificity offered by Dynasore. These results not only affirm dynamin’s role in viral pathogenesis but also highlight Dynasore’s potential as a probe for screening viral entry inhibitors in translational research.

    Expanding Beyond Canonical Models: Comparative Perspective

    Most existing articles, such as this scenario-driven piece, emphasize Dynasore’s use in human cancer or neuroscience workflows, with detailed protocol guidance and troubleshooting. Our analysis pivots to infectious disease, leveraging recent data to illustrate how Dynasore can illuminate host-pathogen interactions and inform antiviral strategy design—a domain less explored in prior reviews.

    Further, while the analysis of Dynasore in viral entry pathway dissection touches on mechanistic studies, our article synthesizes the latest experimental results with a focus on comparative pharmacology, highlighting how Dynasore’s selectivity over other inhibitors (such as nystatin or bafilomycin A1) enables precise mapping of vesicle trafficking and endocytic routes exploited by pathogens.

    Comparative Analysis: Dynasore Versus Alternative Endocytosis Inhibitors

    Experimental dissection of endocytosis often employs a spectrum of pharmacological agents targeting distinct steps of vesicle formation and trafficking. However, specificity, reversibility, and off-target effects vary widely among these compounds.

    Specificity and Mechanistic Precision

    • Dynasore: Noncompetitive, reversible inhibitor of dynamin GTPases; blocks both clathrin- and caveolin-mediated endocytosis at the vesicle scission step.
    • Chlorpromazine: Inhibits clathrin-mediated endocytosis by disrupting clathrin lattice assembly, but affects multiple membrane proteins and induces cytotoxicity at higher concentrations.
    • Methyl-β-cyclodextrin: Disrupts cholesterol-rich microdomains, broadly affecting membrane fluidity and multiple trafficking pathways.
    • Bafilomycin A1: Inhibits endosomal acidification, indirectly affecting some endocytic routes but with broad effects on cellular pH homeostasis.

    Wang et al. (2018) systematically compared these inhibitors. Only Dynasore and ammonium chloride robustly inhibited GCRV104 entry, pinpointing dynamin’s unique role. Notably, nystatin and methyl-β-cyclodextrin showed no inhibition, confirming that the virus did not utilize caveolae- or lipid raft-mediated pathways. This specificity underscores Dynasore’s value in mechanistic infectious disease research, enabling researchers to unambiguously delineate vesicle trafficking pathways involved in pathogen entry.

    Reversibility and Experimental Control

    Dynasore’s reversibility, compared to the often irreversible or cytotoxic effects of alternative inhibitors, allows for temporal control and kinetic studies. Researchers can probe the effects of transient dynamin inhibition on viral entry and subsequent replication, a strategy not feasible with many alternative compounds. This property is crucial for modeling acute versus chronic inhibition scenarios in pathogen-host interactions.

    Advanced Applications: Dynasore in Translational and Disease Models

    Beyond Endocytosis: Signal Transduction and Synaptic Biology

    Although this article focuses on infectious disease, Dynasore’s impact extends to other research domains. Its inhibition of synaptic vesicle endocytosis has made it indispensable for studying neurotransmission and the vesicle trafficking pathway in neurodegenerative disease models. By reversibly arresting vesicle recycling, Dynasore enables the dissection of short-term synaptic plasticity and receptor trafficking dynamics.

    In cancer research, Dynasore-mediated blockade of endocytosis has revealed novel links between membrane trafficking, receptor tyrosine kinase signaling, and tumor cell invasion. For a comparative look at Dynasore’s role in cancer and microbiome signaling, see this in-depth analysis. Our article, in contrast, foregrounds infectious disease modeling and pharmacological validation in the context of viral entry.

    Optimizing Dynasore Use: Solubility and Handling

    For optimal experimental results, Dynasore should be dissolved in DMSO at concentrations ≥16.12 mg/mL, as it is insoluble in water and ethanol. Stock solutions can be enhanced by warming at 37°C or sonication, and are stable for several months at -20°C. This formulation flexibility ensures compatibility with a broad spectrum of in vitro and ex vivo models, from mammalian cells to aquatic organisms, as demonstrated in the GCRV infectious model.

    Researchers should note that Dynasore is supplied as a solid and is intended strictly for scientific research use, not for diagnostic or therapeutic applications. For detailed handling protocols and troubleshooting in vesicle trafficking studies, see the comprehensive guide in this workflow-focused article.

    Conclusion and Future Outlook

    Dynasore, offered by APExBIO, stands as a versatile, rigorously validated dynamin GTPase inhibitor for interrogating endocytic pathways across basic and translational research. Its noncompetitive, reversible inhibition affords unmatched specificity in dissecting dynamin-dependent endocytosis, as evidenced by pivotal studies in viral entry such as Wang et al. (2018). By enabling high-resolution mapping of vesicle trafficking and signal transduction pathways, Dynasore continues to advance our understanding of disease mechanisms and the search for novel therapeutic targets.

    As research expands into complex disease models, including emerging infectious agents and host-pathogen interactions, Dynasore’s unique properties will remain indispensable. Its integration with real-time imaging, genetic manipulation, and systems biology approaches promises even deeper insights into the molecular choreography of endocytosis. For researchers seeking a robust, contextually validated tool for endocytosis research, Dynasore from APExBIO is a proven choice.